LONG-TERM OUTCOMES OF SWITCHING PATIENTS WITH TYPE 2 DIABETES FROM BIPHASIC INSULIN TO BIPHASIC INSULIN ASPART 30/70: AN IMPROVE STUDY SUBGROUP ANALYSIS

被引：0

作者：

Ligthelm, R. ^{[1
]}

Christensen, T. E. ^{[2
]}

Thomsen, T. L. ^{[2
]}

Yang, W. ^{[3
]}

机构：

[1] EHM, Hoofddorp, Netherlands

[2] Novo Nordisk AS, Virum, Denmark

[3] China Japan Friendship Hosp, Beijing, Peoples R China

来源：

VALUE IN HEALTH | 2009年 / 12卷 / 07期

关键词：

D O I：

10.1016/S1098-3015(10)74982-2

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A402 / A402

页数：1

共 50 条

[1] Switching from biphasic human insulin to biphasic insulin aspart 30 in type 2 diabetes: Results from the ASEAN subgroup of the A1chieve study
Hussein, Zanariah
Lim-Abrahan, Mary Anne
Jain, Anand B.
Goh, Su Yen
Soewondo, Pradana
DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 : S24 - S29
[2] IMPROVE (TM) observational study of biphasic insulin aspart 30/70 in patients with Type 2 diabetes mellitus
Kawamori, Ryuzo
Valensi, Paul
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (04) : 507 - 516
[3] Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results
Nobels, Frank
D'Hooge, Dirk
Crenier, Laurent
CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (06) : 1017 - 1026
[4] Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix® 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study
Shah, S.
Benroubi, M.
Borzi, V.
Gumprecht, J.
Kawamori, R.
Shaban, J.
Shestakova, M.
Wenying, Y.
Valensi, P.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (04) : 574 - 582
[5] COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING
Suchankova, E.
Dolezal, T.
Pisarikova, Z.
Rychna, K.
Bartaskova, D.
VALUE IN HEALTH, 2009, 12 (07) : A405 - A406
[6] Treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naive type 2 diabetes patients: long-term effects on diabetesrelated complications
Lammert, M
Palmer, AJ
Roze, S
Valentine, WJ
DIABETOLOGIA, 2005, 48 : A308 - A309
[7] Improvement in Metabolic Control in Type 2 Diabetic Patients after Switching from Biphasic Human Insulin to Biphasic Insulin Aspart 30/70: An Observational Study in Hungary
Geroe, Laszlo
Gyimesi, Andras
Hidvegi, Tibor
DIABETES, 2009, 58 : A527 - A527
[8] Switching patients from human premix insulin to biphasic insulin aspart 30 leads to improved glycaemic control: a subgroup analysis of Korean patients with Type 2 diabetes in the PRESENT study
Oh, Seung Joon
Kim, Jong Hwa
Park, Suk O.
Son, Suk Man
Song, Sun Kyung
Lee, So Ra
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S65 - S65
[9] Biphasic insulin aspart and biphasic human insulin in type 2 diabetes: A comparison
Jacobsen, LV
Bell, PM
McSorely, P
Kristensen, A
DIABETES, 2000, 49 : A112 - A112
[10] Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: a subgroup analysis of the PRESENT Korea NovoMix®study
Jang, H. C.
Lee, S. R.
Vaz, J. A.
DIABETES OBESITY & METABOLISM, 2009, 11 (01): : 20 - 26

← 1 2 3 4 5 →